Authors: Breton, C Chellil, H Kabbaj-Benmansour, M Carnazzi, E Seyer, R Phalipou, S Morin, D Durroux, T Zingg, H Barberis, C Mouillac, B

Citation: C. Breton et al., Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist - Comparison with the human V-1a vasopressin receptor, J BIOL CHEM, 276(29), 2001, pp. 26931-26941

Authors: Cotte, N Balestre, MN Aumelas, A Mahe, E Phalipou, S Morin, D Hibert, M Manning, M Durroux, T Barberis, C Mouillac, B

Citation: N. Cotte et al., Conserved aromatic residues in the transmembrane region VI of the V-1a vasopressin receptor differentiate agonist vs. antagonist ligand binding, EUR J BIOCH, 267(13), 2000, pp. 4253-4263

Authors: Phalipou, S Seyer, R Cotte, N Breton, C Barberis, C Hibert, M Mouillac, B

Citation: S. Phalipou et al., Docking of linear peptide antagonists into the human V-1a vasopressin receptor - Identification of binding domains by photoaffinity labeling, J BIOL CHEM, 274(33), 1999, pp. 23316-23327

Authors: Morin, D Cotte, N Phalipou, S Balestre, MN Ala, Y Sabatier, N Jard, S Vargas, R Antignac, C Dechaux, M Arthus, M Lonergan, M Turner, MS Bichet, DG Hendy, GN Alonso, G Manning, M Hibert, M Mouillac, B Barberis, C

Citation: D. Morin et al., The vasopressin V2 receptor: molecular basis of the nephrogenic diabetes insipidus and identification of residues responsible for binding selectivity, HYDRATION THROUGHOUT LIFE, 1998, pp. 215-221